+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Nuclear Medicine Market by Product (Diagnostic Products, Therapeutic Products), Application (Bone Metastasis, Cardiology, Endocrine Tumor), Type, End-Users - Forecast 2024-2030- Product Image
Global Nuclear Medicine Market by Product (Diagnostic Products, Therapeutic Products), Application (Bone Metastasis, Cardiology, Endocrine Tumor), Type, End-Users - Forecast 2024-2030- Product Image
Sale

Global Nuclear Medicine Market by Product (Diagnostic Products, Therapeutic Products), Application (Bone Metastasis, Cardiology, Endocrine Tumor), Type, End-Users - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5206422
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Nuclear Medicine Market size was estimated at USD 5.14 billion in 2023, USD 5.51 billion in 2024, and is expected to grow at a CAGR of 7.35% to reach USD 8.45 billion by 2030.

The nuclear medicine market refers to the healthcare industry concerned with the use and production of radioisotopes for medical imaging and therapy. The nuclear medicine market includes diagnostic radiopharmaceuticals used in imaging procedures including positron emission tomography (PET) and single-photon emission computed tomography (SPECT), as well as therapeutic radiopharmaceuticals for the treatment of various conditions. The advancements in imaging technologies and the development of new radiopharmaceuticals is influencing the market growth. The rising prevalence of chronic diseases requiring precise diagnostic techniques is enhancing the need for nuclear medicines.

The increased awareness and acceptance of nuclear medicine procedures among patients and healthcare providers is contributing to market growth. However, stringent regulatory barriers and the high cost of product development has limited the adoption of nuclear medicines. High capital investment required for imaging equipment and specialized facilities is a challenging factor for the market. Moreover, manufacturing of novel radioisotopes with safer profiles and higher efficacy is attracting significant opportunities for market growth. The emergence of theranostics, integrating diagnostic and therapeutic capabilities within nuclear agents is also generating growth potential in the market.

Regional Insights

In the Americas region, the United States and Canada, the demand for nuclear medicine is driven by a sophisticated healthcare infrastructure, high healthcare expenditure, and a robust pipeline of radiopharmaceuticals. The United States and Canada remain the largest region for nuclear medicine due to its early adoption of advanced diagnostics, substantial investment in research and development, and favorable reimbursement policies. The European market is characterized by a high level of economic development, a well-established healthcare system, and significant government funding.

In the European region, the demand for diagnostic and therapeutic radiopharmaceuticals is balanced by cost-containment measures and emphasis on evidence-based clinical outcomes. The United Arab Emirates (UAE) and Saudi Arabia are key contributors in the Middle East region, contributing to the market growth, with initiatives to increase accessibility to nuclear medical services. In the APAC region, china's nuclear medicine sector is rapidly expanding, due to government investment in healthcare infrastructure and an increasing incidence of cancer and cardiovascular diseases. Japan and India's nuclear medicine sector is growing due to rising healthcare awareness and improvements in healthcare facilities.

Market Trends by Segment

  • Product: Significance of diagnostic products in nuclear medicines
  • End-Users: Diverse applications in hospitals and diagnostic centers

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Shine Reaches Supply Agreement with Nucleus RadioPharma

Shine Technologies has established a long-term partnership with Nucleus RadioPharma, foregrounding the provision of Lutetium-177 (Lu-177) to fortify Nucleus's radioligand therapies. This partnership is set to enhance treatments for neuroendocrine tumors and prostate cancer, securing a steady isotope supply for both current and future clinical trials aimed at broadening the spectrum of targeted radiopharmaceuticals in oncology.

ITM and Canadian Nuclear Labs Launch New Company

ITM Isotope Technologies Munich SE (ITM) and Canadian Nuclear Laboratories (CNL) have announced the formation of Actineer, a dedicated company aimed at enhancing the production of actinium-225 (Ac-225), a highly sought-after radioisotope with potent applications in cancer treatment. This strategic partnership paves the way for increased availability of this cutting-edge therapeutic isotope, promising to be a game-changer in the treatment of malignancies.

Life Healthcare Set to Acquire Nuclear-medicine Operation in SA

Life Healthcare Group, has strategically enhanced its South African portfolio through the acquisition of the non-clinical imaging operations of TheraMed Nuclear in Gauteng. This move strengthens Life Healthcare's presence in advanced medical imaging by incorporating nuclear and molecular imaging capabilities, thus reinforcing its commitment to the early detection and precise treatment planning for diseases such as cancer.

Key Company Profiles

The report delves into recent significant developments in the Nuclear Medicine Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Bayer AG, BJ Madan & Co., Bracco S.p.A., BWX Technologies, Inc. by Framatome, Cardinal Health, Inc., Curium, Eckert & Ziegler Radiopharma GmbH, Eczacibaşi Monrol Nuclear Products Co., GE Healthcare, IBA Radiopharma Solutions, Institute of Isotopes Co., Ltd., Isotope Joint Stock Company, Isotopia Molecular Imaging, Jubilant DraxImage, Inc., Lantheus Holdings, Inc., Nordic Nanovector ASA by Thor Medical, Nordion (Canada) Inc. by Sotera Health LLC, Northstar Medical Technologies LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings LLC, Radiopharm Theranostics Limited, SHINE Technologies, LLC, and Sinotau Pharmaceuticals Group.

This research report offers invaluable insights into various crucial aspects of the Nuclear Medicine Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Incidence and Prevalence of Cancer Worldwide
5.1.1.2. Increasing Use of PET and SPECT to Diagnose Heart disease and Neurological Disorders
5.1.1.3. International Organizations’ Initiatives and Awareness Supporting Nuclear Medicine
5.1.2. Restraints
5.1.2.1. Shorter Half-Life of Nuclear Medicine
5.1.3. Opportunities
5.1.3.1. Emerging Popularity of Theranostics in Nuclear Medicine
5.1.3.2. Continuous Product Developments and Advancements in Patented Technologies
5.1.4. Challenges
5.1.4.1. Lack of Knowledge, Training, and Availability of Nuclear Medicine in Developing Countries
5.1.4.2. Limited Availability of Skilled Radiologists and Practitioners Worldwide
5.2. Market Segmentation Analysis
5.2.1. Product: Significance of diagnostic products in nuclear medicines
5.2.2. End-Users: Diverse applications in hospitals and diagnostic centers
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Nuclear Medicine Market, by Product
6.1. Introduction
6.2. Diagnostic Products
6.3. Therapeutic Products
7. Nuclear Medicine Market, by Application
7.1. Introduction
7.2. Bone Metastasis
7.3. Cardiology
7.4. Endocrine Tumor
7.5. Lymphoma
7.6. Oncology
7.7. Thyroid
8. Nuclear Medicine Market, by Type
8.1. Introduction
8.2. Diagnostic
8.3. Therapeutic
9. Nuclear Medicine Market, by End-Users
9.1. Introduction
9.2. Hospitals & Diagnostic Centers
9.3. Research institutes
10. Americas Nuclear Medicine Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Nuclear Medicine Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Nuclear Medicine Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Shine Reaches Supply Agreement with Nucleus RadioPharma
13.3.2. ITM and Canadian Nuclear Labs Launch New Company
13.3.3. Life Healthcare Set to Acquire Nuclear-medicine Operation in SA
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. NUCLEAR MEDICINE MARKET RESEARCH PROCESS
FIGURE 2. NUCLEAR MEDICINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NUCLEAR MEDICINE MARKET DYNAMICS
FIGURE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. NUCLEAR MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. NUCLEAR MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. NUCLEAR MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 77. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY REGION, 2018-2023 (USD MILLION)
TABLE 78. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY REGION, 2024-2030 (USD MILLION)
TABLE 79. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 80. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 81. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 82. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 83. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
TABLE 84. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
TABLE 85. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
TABLE 86. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
TABLE 87. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
TABLE 88. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
TABLE 89. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 90. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 91. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
TABLE 92. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
TABLE 93. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
TABLE 94. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
TABLE 95. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
TABLE 96. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
TABLE 97. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
TABLE 98. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
TABLE 99. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 100. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 101. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 102. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 103. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 104. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 105. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 108. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 109. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
TABLE 110. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
TABLE 111. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
TABLE 112. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
TABLE 113. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 114. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 115. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 116. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 117. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
TABLE 118. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
TABLE 119. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
TABLE 124. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
TABLE 125. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
TABLE 126. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
TABLE 127. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 128. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 129. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 130. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 131. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 134. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 135. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
TABLE 136. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
TABLE 137. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
TABLE 138. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
TABLE 139. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 140. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 141. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 142. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 143. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
TABLE 144. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
TABLE 145. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 148. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 149. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
TABLE 150. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
TABLE 151. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
TABLE 152. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
TABLE 153. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 154. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 155. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 158. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 159. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
TABLE 160. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
TABLE 161. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
TABLE 162. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
TABLE 163. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 164. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 165. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 166. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 167. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
TABLE 168. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
TABLE 169. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
TABLE 174. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
TABLE 175. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
TABLE 176. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
TABLE 177. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 178. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 179. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 180. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 181. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 182. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 183. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
TABLE 184. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
TABLE 185. CANADA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
TABLE 186. CANADA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
TABLE 187. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 188. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 189. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 190. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 191. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
TABLE 192. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
TABLE 193. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. CANADA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. CANADA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
TABLE 198. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
TABLE 199. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
TABLE 200. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
TABLE 201. CANADA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 202. CANADA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 203. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 206. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 207. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
TABLE 208. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
TABLE 209. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
TABLE 210. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
TABLE 211. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 212. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 213. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 214. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 215. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
TABLE 216. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
TABLE 217. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
TABLE 222. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
TABLE 223. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
TABLE 224. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
TABLE 225. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 226. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 227. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 228. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 229. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 230. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 231. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
TABLE 232. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
TABLE 233. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
TABLE 234. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
TABLE 235. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 236. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 237. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 238. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 239. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
TABLE 240. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
TABLE 241. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
TABLE 246. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
TABLE 247. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
TABLE 248. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
TABLE 249. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 250. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 251. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 252. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 256. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
TABLE 258. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
TABLE 260. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 262. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 264. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
TABLE 266. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 270. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
TABLE 272. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
TABLE 274. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 276. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 278. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 279. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 280. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 281. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 282. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 283. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
TABLE 284. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
TABLE 285. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
TABLE 286. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
TABLE 287. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 288. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 289. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 290. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 291. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
TABLE 292. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
TABLE 293. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 294. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 295. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 296. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 297. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
TABLE 298. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
TABLE 299. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
TABLE 300. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
TABLE 301. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 302. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 303. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 304. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 305. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 306. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 307. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
TABLE 308. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
TABLE 309. CHINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
TABLE 310. CHINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
TABLE 311. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 312. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 313. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 314. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 315. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
TABLE 316. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
TABLE 317. CHINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. CHINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. CHINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 320. CHINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 321. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
TABLE 322. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
TABLE 323. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
TABLE 324. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
TABLE 325. CHINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 326. CHINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 327. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 328. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 329. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 330. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 331. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
TABLE 332. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
TABLE 333. INDIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
TABLE 334. INDIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
TABLE 335. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 336. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 337. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 338. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 339. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
TABLE 340. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
TABLE 341. INDIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 342. INDIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 343. INDIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 344. INDIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 345. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
TABLE 346. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
TABLE 347. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
TABLE 348. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
TABLE 349. INDIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 350. INDIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 351. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 352. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 353. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 354. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 355. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
TABLE 356. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
TABLE 357. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
TABLE 358. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
TABLE 359. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
TABLE 360. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
TABLE 361. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 362. I

Companies Mentioned

  • Actinium Pharmaceuticals, Inc.
  • Bayer AG
  • BJ Madan & Co.
  • Bracco S.p.A.
  • BWX Technologies, Inc. by Framatome
  • Cardinal Health, Inc.
  • Curium
  • Eckert & Ziegler Radiopharma GmbH
  • Eczacibaşi Monrol Nuclear Products Co.
  • GE Healthcare
  • IBA Radiopharma Solutions
  • Institute of Isotopes Co., Ltd.
  • Isotope Joint Stock Company
  • Isotopia Molecular Imaging
  • Jubilant DraxImage, Inc.
  • Lantheus Holdings, Inc.
  • Nordic Nanovector ASA by Thor Medical
  • Nordion (Canada) Inc. by Sotera Health LLC
  • Northstar Medical Technologies LLC
  • Novartis AG
  • NTP Radioisotopes SOC Ltd.
  • PharmaLogic Holdings LLC
  • Radiopharm Theranostics Limited
  • SHINE Technologies, LLC
  • Sinotau Pharmaceuticals Group

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.51 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.45 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Global Radiopharmaceuticals Market by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), Application - Forecast 2024-2030 - Product Image

Global Radiopharmaceuticals Market by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), Application - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy)), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy)), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 170 Pages
  • Global
From
Nuclear Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Product Type Coverage, Application Coverage, End User Coverage, Geographic Coverage and By Company) - Product Image

Nuclear Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Product Type Coverage, Application Coverage, End User Coverage, Geographic Coverage and By Company)

  • Report
  • 206 Pages
  • Global
Global Prostate Cancer Nuclear Medicine Diagnostics Market by Type (PET, SPECT), Product (C-11, F-18, Ga 68 PSMA) - Forecast 2024-2030 - Product Image

Global Prostate Cancer Nuclear Medicine Diagnostics Market by Type (PET, SPECT), Product (C-11, F-18, Ga 68 PSMA) - Forecast 2024-2030

  • Report
  • 196 Pages
  • Global
From
Global Nuclear Medicine Therapeutics Market Analysis & Forecast 2024-2034: Market By Type; By Application; By End-user; and By Region - Product Image

Global Nuclear Medicine Therapeutics Market Analysis & Forecast 2024-2034: Market By Type; By Application; By End-user; and By Region

  • Report
  • 145 Pages
  • Global
From

About the Nuclear Medicine Market

Nuclear Medicine is a field of medicine that uses radioactive materials to diagnose and treat diseases, particularly cancer. Nuclear Medicine is used to detect and monitor the progression of cancer, as well as to provide targeted treatments. It is used to detect cancer cells in the body, to measure the effectiveness of cancer treatments, and to provide targeted radiation therapy. Nuclear Medicine can also be used to detect and monitor the spread of cancer to other parts of the body. Nuclear Medicine is used in combination with other treatments, such as chemotherapy and surgery, to provide a comprehensive approach to cancer care. It is also used to provide palliative care, to reduce pain and improve quality of life for cancer patients. Nuclear Medicine is a rapidly growing field, with new technologies and treatments being developed to improve the diagnosis and treatment of cancer. Companies in the Nuclear Medicine market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Toshiba Medical Systems. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.